Carillon Tower Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $3.99M | Buy |
158,677
+1,200
| +0.8% | +$30.2K | 0.02% | 426 |
|
|
2020
Q3 | $3.28M | Buy |
157,477
+20,742
| +15% | +$432K | 0.04% | 375 |
|
|
2020
Q2 | $3.25M | Sell |
136,735
-3,800
| -3% | -$90.2K | 0.03% | 404 |
|
|
2020
Q1 | $2.53M | Sell |
140,535
-13,600
| -9% | -$245K | 0.02% | 389 |
|
|
2019
Q4 | $3.66M | Sell |
154,135
-185,775
| -55% | -$4.41M | 0.02% | 417 |
|
|
2019
Q3 | $9.34M | Sell |
339,910
-86,300
| -20% | -$2.37M | 0.07% | 337 |
|
|
2019
Q2 | $14.1M | Sell |
426,210
-136,150
| -24% | -$4.51M | 0.1% | 291 |
|
|
2019
Q1 | $19.7M | Sell |
562,360
-60,100
| -10% | -$2.11M | 0.14% | 244 |
|
|
2018
Q4 | $20.7M | Buy |
622,460
+233,125
| +60% | +$7.74M | 0.18% | 211 |
|
|
2018
Q3 | $19.6M | Sell |
389,335
-48,165
| -11% | -$2.43M | 0.14% | 237 |
|
|
2018
Q2 | $26.2M | Buy |
437,500
+268,025
| +158% | +$16M | 0.21% | 175 |
|
|
2018
Q1 | $7.76M | Buy |
+169,475
| New | +$7.76M | 0.06% | 332 |
|